Pages

Thursday, February 9, 2012

February 9, 2012

Here is today's mail:

  • A letter from EmblemHealth
Informing us that now that Atorvastatin, a generic form of Lipitor is available, they will no longer cover Lipitor without prior approval, and it will only be covered as a nonpreferred brand.  Of course, that means a higher copay.  The problem is that Pfizer was subsidizing the cost of Lipitor so that the copay was only $4, and now we will pay more for the generic than we did for the name brand.

  • A fundraising appeal from the Jewish National Fund
  • A fundraising appeal from the Federation of Jewish Men's Clubs
  • The Spring/Summer edition of The Great Neck Public Schools Adult Program Continuing Education catalogue
  • A copy of Homes & Estates Magazine
  • A Semi-Annual Report from First Trust Senior Floating Rate Income Fund II
  • This week's edition of The Great Neck Record

No comments:

Post a Comment